These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12077892)

  • 1. [Drug therapy of Alzheimer's disease].
    Sulkava R
    Duodecim; 2000; 116(24):2867-73. PubMed ID: 12077892
    [No Abstract]   [Full Text] [Related]  

  • 2. Alternatives for Alzheimer's. Three basic approaches offer help and hope.
    Reese D
    Contemp Longterm Care; 2002 Feb; 25(2):8-9. PubMed ID: 11842532
    [No Abstract]   [Full Text] [Related]  

  • 3. Acetylcholinesterase inhibitors, neuropsychiatric symptoms, and Alzheimer's disease subtypes: an alternate hypothesis to global cognitive enhancement.
    Brousseau G; Rourke BP; Burke B
    Exp Clin Psychopharmacol; 2007 Dec; 15(6):546-54. PubMed ID: 18179307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current treatments for Alzheimer's disease: cholinesterase inhibitors.
    Doody RS
    J Clin Psychiatry; 2003; 64 Suppl 9():11-7. PubMed ID: 12934969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's drugs deliver fringe benefits. Cholinesterase inhibitors improve more than just memory.
    Auerbach SH
    Health News; 2003 Mar; 9(3):1-2. PubMed ID: 12703432
    [No Abstract]   [Full Text] [Related]  

  • 6. Cholinesterase inhibitors for Alzheimer's disease.
    Hitzeman N
    Am Fam Physician; 2006 Sep; 74(5):747-9. PubMed ID: 16970018
    [No Abstract]   [Full Text] [Related]  

  • 7. How to define treatment success using cholinesterase inhibitors.
    Thal LJ
    Int J Geriatr Psychiatry; 2002 Apr; 17(4):388-90. PubMed ID: 11994895
    [No Abstract]   [Full Text] [Related]  

  • 8. Effective pharmacologic management of Alzheimer's disease.
    Farlow MR; Cummings JL
    Am J Med; 2007 May; 120(5):388-97. PubMed ID: 17466645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of Alzheimer's disease with acetylcholinesterase inhibitors].
    Dartigues JF; Poncet M
    Rev Neurol (Paris); 2008 Apr; 164 Spec No 2():F107. PubMed ID: 18680827
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of Alzheimer's disease].
    Soininen H
    Duodecim; 1997; 113(18):1739-46. PubMed ID: 10892065
    [No Abstract]   [Full Text] [Related]  

  • 11. Atomoxetine augmentation of cholinesterase inhibitor therapy in patients with Alzheimer disease: 6-month, randomized, double-blind, placebo-controlled, parallel-trial study.
    Mohs RC; Shiovitz TM; Tariot PN; Porsteinsson AP; Baker KD; Feldman PD
    Am J Geriatr Psychiatry; 2009 Sep; 17(9):752-9. PubMed ID: 19700948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on Alzheimer drugs (galantamine).
    Raskind MA
    Neurologist; 2003 Sep; 9(5):235-40. PubMed ID: 12971834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating Alzheimer's disease with cholinergic drugs, Part I.
    Terpstra T; Terpstra T
    Nurse Pract; 1998 Nov; 23(11):90, 92, 97 passim. PubMed ID: 9834506
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis.
    Harry RD; Zakzanis KK
    Hum Psychopharmacol; 2005 Apr; 20(3):183-7. PubMed ID: 15700322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.
    Beier MT
    Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the horizon: pathways for drug development in Alzheimer's disease.
    Hake AM; Farlow MR
    Clin Geriatr Med; 2004 Feb; 20(1):141-52. PubMed ID: 15062492
    [No Abstract]   [Full Text] [Related]  

  • 17. Cholinesterase inhibitors: A new class of psychotropic compounds.
    Cummings JL
    Am J Psychiatry; 2000 Jan; 157(1):4-15. PubMed ID: 10618007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cholinesterase inhibitors in Alzheimer's disease].
    Ventura M; Sternon J
    J Pharm Belg; 2001; 56(3):62-8. PubMed ID: 11508260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should cholinesterase inhibitors be used to treat Alzheimer's disease?
    Finucane TE; Gilstad JR
    Nat Clin Pract Neurol; 2006 Mar; 2(3):118-9. PubMed ID: 16932534
    [No Abstract]   [Full Text] [Related]  

  • 20. Benefits of combining donepezil plus traditional Japanese herbal medicine on cognition and brain perfusion in Alzheimer's disease: a 12-week observer-blind, donepezil monotherapy controlled trial.
    Maruyama M; Tomita N; Iwasaki K; Ootsuki M; Matsui T; Nemoto M; Okamura N; Higuchi M; Tsutsui M; Suzuki T; Seki T; Kaneta T; Furukawa K; Arai H
    J Am Geriatr Soc; 2006 May; 54(5):869-71. PubMed ID: 16696770
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.